Total Funding
82
76
Total FundingPost-IPO Equity raised
Growth Score 82 in past quarter
-14 pts
Heat Score 76 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9446
Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.
- Luisa Ingargiola: Chief Financial Officer
- David K Jin: President/CEO/Co-Founder
About the Company
Avalon GloboCare Corp is a clinical-stage biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology and their clinical applications, as well as healthcare facility management through its core platforms, namely "Avalon Cell" and "Avalon Rehab."